Related Experiment Videos
Tc-99m galactosyl-neoglycoalbumin hepatic scintigraphy in fulminant hepatic failure
1Nuclear Medicine Service, Hospital Clinic i Provincial, Barcelona, Spain.
Clinical Nuclear Medicine
|April 1, 1995
Abstract:
Tc-99m galactosyl-neoglycoalbumin (NGA) is a new liver imaging agent that specifically binds to a hepatocyte specific membrane receptor, the hepatic binding protein. Scintigraphy with Tc-99m NGA is a noninvasive method that provides functional images of the liver. This report deals with one case of fulminant hepatic failure in which hepatic scintigraphy with Tc-99m NGA predicted hepatic recovery before clinical and biochemical parameters, being a prognostic index in this patient.